EUCTR2010-018369-48-AT进行中（未招募）1 期
Der Einfluss von Adalimumab auf kardiovaskuläre und metabolische Risikofaktoren in der Therapie von Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris im Vergleich zu einer Standardtherapie (Fumarsäureester) - CASTIP(Comorbidities and systemic therapies in psoriasis)
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •# Chronic severe plaque type psoriasis (PASI <10) requiring anti TNF alpha therapy; Contraindication or therapeutic failure of 2 conventional systemic treatments
- •# PASI = 10, BSA = 10
- •# Age 18 – 80 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •# Allergies and/or Sensitivity to the IMP
- •# Patients with malignoma or autoimmune disease or other severe impairment of health
- •#Patients with active tuberculosis or other chronic, severe or opportunistic infections; patients with sepsis or positive tuberculosis screening
- •#Patients with cardial insufficiency (NYHA Class III/IV)
- •#Patients with gastroinestinal, hepatic, renal diseases, gastric/duodenal ulcers
- •# Women of childbearing potential not taking contraceptive measures
- •# Pregnant or breastfeeding women
- •# Patients who are unable to understand or comply with the study protocol
研究者
相似试验
进行中（未招募）
不适用
The effect of Adalimumab (Humira) on vascular abnormalities in rheumatoid arthritis. A pilot study.Rheumatoid Arthritis.EUCTR2005-000129-47-SEDept. of Rhematology UMAS15
已完成
2 期
?Effect of amilodipine on heart function and cardiac iron deposition in ß-thalassemia patientsIRCT20090613002027N15Sari University of Medical Sciences62
招募中
3 期
Adalimumab effect on COVID-19IRCT20171105037262N4Bagheiat-allah University of Medical Sciences100
进行中（未招募）
不适用
THE ANTI-ANGIOGENIC EFFECTS OF ADALIMUMAB INCROHN`S DISEASE - NDCrohn`s DiseaseMedDRA version: 9.1Level: LLTClassification code 10038283Term: Regional enteritis of small intestine with large intestineEUCTR2009-011763-37-ITISTITUTO CLINICO HUMANITAS
已完成
4 期
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint DiseaseRheumatoid ArthritisCardiovascular DiseaseNCT01893996Jonathan Graf63